{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T11:53:44Z","timestamp":1720785224482},"reference-count":36,"publisher":"Media Sphere Publishing House","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vestn. oftal'mol."],"published-print":{"date-parts":[[2018]]},"DOI":"10.17116\/oftalma2018134051208","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T09:36:58Z","timestamp":1543570618000},"page":"208","source":"Crossref","is-referenced-by-count":1,"special_numbering":"Vyp. 2","title":["Hypotensive efficacy of bimatoprost in monotherapy of primary open-angle glaucoma"],"prefix":"10.17116","volume":"134","author":[{"given":"S. Yu.","family":"Petrov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. V.","family":"Kozlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. S.","family":"Zinina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Volzhanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. V.","family":"Kravchik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/oftalma2018134051208-1","doi-asserted-by":"publisher","DOI":"10.1590\/S0042-96862004001100009"},{"key":"key-10.17116\/oftalma2018134051208-2","unstructured":"European Glaucoma Society. Terminology and guidelines for glaucoma. 4th ed: Savona, Italy PubliComm; 2014."},{"key":"key-10.17116\/oftalma2018134051208-3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013"},{"key":"key-10.17116\/oftalma2018134051208-4","unstructured":"Nesterov AP, Alekseev VN, Alekseev IB, Amirov AN, Astakhov YuS, Balalin SV. Natsionalnoe rukovodstvo po glaukome dlya praktikuyuschikh vrachei. Tretye izdanie, ispr. i dop. M.: GEOTAR-Media; 2015. (In Russ.)"},{"key":"key-10.17116\/oftalma2018134051208-5","doi-asserted-by":"crossref","unstructured":"Leske MC, Heijl A, Hussein M., Bengtsson B., Hyman L., Komaroff E., Early Manifest Glaucoma Trial G. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121(1):48-56.","DOI":"10.1001\/archopht.121.1.48"},{"key":"key-10.17116\/oftalma2018134051208-6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.10.053"},{"key":"key-10.17116\/oftalma2018134051208-7","unstructured":"Egorov EA. Hypotensive treatment of glaucoma. RMJ Klinicheskaya Oftalmologiya. 2000;1(1):6. (In Russ.)"},{"key":"key-10.17116\/oftalma2018134051208-8","unstructured":"Erichev VP. Main directions of hypotensive treatment of primary glaucoma patients. Russkiy oftalmologicheskiy zhurnal. 2000;1(1):18. (In Russ.)"},{"key":"key-10.17116\/oftalma2018134051208-9","unstructured":"Erichev VP, Dugina AE, Mazurova YuV. Fixed drug combinations: modern approach to glaucoma therapy. Glaucoma. 2010;(1):62-65. (In Russ.)"},{"key":"key-10.17116\/oftalma2018134051208-10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.09.005"},{"key":"key-10.17116\/oftalma2018134051208-11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701674"},{"key":"key-10.17116\/oftalma2018134051208-12","doi-asserted-by":"crossref","unstructured":"Moore W, Nischal KK. Pharmacologic management of glaucoma in childhood. Paediatr Drugs. 2007;9(2):71-79.","DOI":"10.2165\/00148581-200709020-00001"},{"key":"key-10.17116\/oftalma2018134051208-13","doi-asserted-by":"publisher","DOI":"10.153\/SOPH01400114"},{"key":"key-10.17116\/oftalma2018134051208-14","doi-asserted-by":"crossref","unstructured":"Resul B, Stjernschantz J, No K, Liljebris C, Selen G, Astin M, Karlsson M, Bito LZ. Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents. J Med Chem. 1993;36(2):243-248.","DOI":"10.1021\/jm00054a008"},{"key":"key-10.17116\/oftalma2018134051208-15","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S61444"},{"key":"key-10.17116\/oftalma2018134051208-16","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A178"},{"key":"key-10.17116\/oftalma2018134051208-17","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903292649"},{"key":"key-10.17116\/oftalma2018134051208-18","doi-asserted-by":"publisher","DOI":"10.1089\/108076803762718105"},{"key":"key-10.17116\/oftalma2018134051208-19","doi-asserted-by":"crossref","unstructured":"Eisenberg DL, Toris CB, Camras CB. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs. Surv Ophthalmol. 2002;47 (suppl 1):105-115.","DOI":"10.1016\/S0039-6257(02)00327-2"},{"key":"key-10.17116\/oftalma2018134051208-20","doi-asserted-by":"publisher","DOI":"10.1089\/108076803321637627"},{"key":"key-10.17116\/oftalma2018134051208-21","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2003.12.014"},{"key":"key-10.17116\/oftalma2018134051208-22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.06.028"},{"key":"key-10.17116\/oftalma2018134051208-23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.02.006"},{"key":"key-10.17116\/oftalma2018134051208-24","doi-asserted-by":"crossref","unstructured":"Brubaker RF, Schoff EO, Nau CB, Carpenter SP, Chen K, Vandenburgh AM. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am J Ophthalmol. 2001;131(1):19-24.","DOI":"10.1016\/S0002-9394(00)00843-6"},{"key":"key-10.17116\/oftalma2018134051208-25","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.047837"},{"key":"key-10.17116\/oftalma2018134051208-26","doi-asserted-by":"crossref","unstructured":"Brandt JD, VanDenburgh AM, Chen K, Whitcup SM., Bimatoprost Study G. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trial. Ophthalmology. 2001;108(6):1023-1031; discussion 1032.","DOI":"10.1016\/S0161-6420(01)00584-X"},{"key":"key-10.17116\/oftalma2018134051208-27","doi-asserted-by":"crossref","unstructured":"DuBiner H, Cooke D, Dirks M, Stewart WC, VanDenburgh AM, Felix C. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost. Surv Ophthalmol. 2001;45(suppl 4):353-360.","DOI":"10.1016\/S0039-6257(01)00212-0"},{"key":"key-10.17116\/oftalma2018134051208-28","doi-asserted-by":"crossref","unstructured":"Gandolfi S, Simmons ST, Sturm R, Chen K, Vandenburgh AM, Bimatoprost Study G. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Ther. 2001;18(3):110-121.","DOI":"10.1007\/BF02850299"},{"key":"key-10.17116\/oftalma2018134051208-29","doi-asserted-by":"crossref","unstructured":"Sherwood M, Brandt J, Bimatoprost Study G. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol. 2001;45(suppl 4):361-368.","DOI":"10.1016\/S0039-6257(01)00219-3"},{"key":"key-10.17116\/oftalma2018134051208-30","doi-asserted-by":"crossref","unstructured":"Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM, Bimatoprost\/Latanoprost Study G. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol. 2003;135(1):55-63.","DOI":"10.1016\/S0002-9394(02)01827-5"},{"key":"key-10.17116\/oftalma2018134051208-31","doi-asserted-by":"crossref","unstructured":"Simmons ST, Dirks MS, Noecker RJ. Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials. Adv Ther. 2004;21(4):247-262.","DOI":"10.1007\/BF02850157"},{"key":"key-10.17116\/oftalma2018134051208-32","doi-asserted-by":"crossref","unstructured":"Dirks MS, Noecker RJ, Earl M, Roh S, Silverstein SM, Williams RD. A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma. Adv Ther. 2006;23(3):385-394.","DOI":"10.1007\/BF02850159"},{"key":"key-10.17116\/oftalma2018134051208-33","doi-asserted-by":"crossref","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, 2nd, Wilson MR, Gordon MO. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701-713; discussion 829-730.","DOI":"10.1001\/archopht.120.6.701"},{"key":"key-10.17116\/oftalma2018134051208-34","doi-asserted-by":"crossref","unstructured":"Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, Mills RP, Group CS. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108(11):1943-1953.","DOI":"10.1016\/S0161-6420(01)00873-9"},{"key":"key-10.17116\/oftalma2018134051208-35","unstructured":"Glaucoma. Natsionalnoe rukovodstvo. Pod red. Egorova E.A. M.: GEOTAR-Media, 2013. (In Russ.)"},{"key":"key-10.17116\/oftalma2018134051208-36","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S59197"}],"container-title":["Vestnik oftal'mologii"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T10:31:24Z","timestamp":1573036284000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/vestnik-oftalmologii\/2018\/5\/downloads\/ru\/10042465X2018052208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"alternative-id":["oftalma2018134051208"],"URL":"https:\/\/doi.org\/10.17116\/oftalma2018134051208","relation":{},"ISSN":["0042-465X"],"issn-type":[{"value":"0042-465X","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}